These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11485050)

  • 1. Relationship between hydrophobicity and beta-blocking potencies, affinities or dissociation of beta-blockers from beta-adrenoceptors.
    Nakamura T; Hosohata Y; Hosohata K; Hattori K; Suzuki J; Nagatomo T
    Res Commun Mol Pathol Pharmacol; 1999; 106(3):203-11. PubMed ID: 11485050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blocking potency and selectivity of bopindolol and its two metabolites for beta 1- and beta 2-adrenergic receptors as assessed by radioligand binding assay.
    Sakuma N; Tsuchihashi H; Hosohata Y; Akashi H; Kinami J; Nagatomo T
    J Pharmacobiodyn; 1991 May; 14(5):250-5. PubMed ID: 1685186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bopindolol is a slowly dissociating beta 1-adrenoceptor antagonist when compared to other beta-blockers.
    Hosohata Y; Sasaki K; Shen Y; Hattori K; Suzuki J; Nagatomo T
    Biol Pharm Bull; 1995 Aug; 18(8):1066-71. PubMed ID: 8535397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bopindolol: a slowly dissociating antagonist from the beta-adrenoceptors in guinea pig atria.
    Hosohata Y; Hattori K; Shen Y; Okuyama M; Kaneko H; Ohnuki T; Suzuki J; Nagatomo T
    Pharmacology; 1998 Oct; 57(4):180-7. PubMed ID: 9730775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of 125I-iodocyanopindolol binding to beta-adrenergic and serotonin-1B receptors of rat brain: selectivity of beta-adrenergic agents.
    Tsuchihashi H; Nakashima Y; Kinami J; Nagatomo T
    Jpn J Pharmacol; 1990 Feb; 52(2):195-200. PubMed ID: 1968985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium.
    Lowe MD; Lynham JA; Grace AA; Kaumann AJ
    Br J Pharmacol; 2002 Jan; 135(2):451-61. PubMed ID: 11815381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivity of bunitrolol for beta 1- and beta 2-adrenergic receptors and 5HT1B-receptors: assessment by biphasic Scatchard plots and biphasic displacement curve analysis with 125I-iodocyanopindolol and 3H-CGP12177.
    Tsuchihashi H; Nagotomo T; Imai S
    Jpn J Pharmacol; 1989 Jun; 50(2):93-100. PubMed ID: 2570175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of affinities of propranolol and bopindolol to membranes from COS-7 cell transiently transfected with beta-1- and beta-2-adrenoceptors using a radioligand-binding assay method.
    Nakamura T; Suzuki A; Ohnuki T; Hattori K; Watanabe K; Kurose H; Nagao T; Nagatomo T
    Pharmacology; 2000 Jul; 61(1):6-10. PubMed ID: 10895074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interactivities with lipid membranes differentially characterize selective and nonselective beta1-blockers.
    Mizogami M; Takakura K; Tsuchiya H
    Eur J Anaesthesiol; 2010 Sep; 27(9):829-34. PubMed ID: 20601889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding characteristics of 3H-CGP12177 to beta-adrenoceptors in rat myocardial membranes.
    Tsuchihashi H; Yokoyama H; Nagatomo T
    Jpn J Pharmacol; 1989 Jan; 49(1):11-9. PubMed ID: 2566701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic administration of bopindolol on the binding characteristics of cardiac alpha 1H-, alpha 1L-, beta 1- and beta 2-adrenoceptor subtypes in cardiac muscles of spontaneously hypertensive rats (SHR).
    Hosohata Y; Sasaki K; Maruyama K; Ohnuki T; Hattori K; Suzuki J; Watanabe K; Nagatomo T
    Biol Pharm Bull; 1996 Jul; 19(7):932-5. PubMed ID: 8839963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of beta 2- and beta 3-adrenoceptors in rat white adipose tissues by radioligand binding assay.
    Kubo S; Matsuda A; Ohnuki T; Hattori K; Suzuki J; Nagatomo T
    Biol Pharm Bull; 1997 Feb; 20(2):142-8. PubMed ID: 9057975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding.
    Sarsero D; Molenaar P; Kaumann AJ; Freestone NS
    Br J Pharmacol; 1999 Dec; 128(7):1445-60. PubMed ID: 10602323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of beta-adrenoceptor populations in cat and guinea-pig left atria.
    Molenaar P; McPherson GA; Malta E; Raper C
    J Pharm Pharmacol; 1985 Apr; 37(4):257-60. PubMed ID: 2860224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustaining effects of bopindolol on inhibitory chronotropic actions in guinea pig atria.
    Hattori K; Suzuki J; Hosohata Y; Ohnuki T; Nakamura T; Watanabe K; Muramatsu I; Nagatomo T
    Pharmacology; 1999 Oct; 59(4):183-91. PubMed ID: 10474078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative potencies of various beta-adrenoceptor antagonists (BAA) at the level of the human myocardial beta-adrenoceptor-adenylate cyclase (AC) complex. Is intrinsic sympathomimetic activity (ISA) due to AC activation?
    Golf S; Hansson V
    Scand J Clin Lab Invest; 1986 Apr; 46(2):121-30. PubMed ID: 2872714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative inotropic effects and the hydrophobicity of beta-adrenergic blocking agents.
    Harada S; Ban T; Fujita T; Koshiro A
    Arch Int Pharmacodyn Ther; 1981 Aug; 252(2):262-71. PubMed ID: 6118107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-receptor blocking potencies of the three newly synthesized beta-adrenergic antagonists (S-596, K-351, N-696) as assessed with the radioligand binding assay method in rat cardiac muscle membrane treated with neuraminidase.
    Nagatomo T; Tsuchihashi H; Sasaki M; Nakagawa Y; Nakahara H; Imai S
    Jpn J Pharmacol; 1984 Feb; 34(2):249-54. PubMed ID: 6205196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of binding sites of CGP12177, a beta 3-adrenoceptor partial agonist, and carteolol, a beta 1/beta 2-adrenoceptor partial agonist, to the beta-adrenoceptors in guinea-pig taenia caecum.
    Koike K; Takayanagi I; Yamazaki M
    Can J Physiol Pharmacol; 1996 Aug; 74(8):928-33. PubMed ID: 8960382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.